跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,899 条关于
“FMC-242”
全部
3,899
临床试验
2,229
药物
1,300
机构
40
资讯
330
11个月前
Frontier Medicines Unveils FMC-242, Novel PI3Kα/RAS Inhibitor Targeting Cancer's Most Common Genetic Drivers
5个月前
Frontier Medicines Appoints Former Seagen CEO David Epstein to Board as Company Advances Covalent Precision Medicine Pipeline
去年
Frontier Medicines Presents Breakthrough Data on FMC-220, First-in-Class p53 Y220C Activator for Cancer Treatment
5个月前
LG Chem Acquires Worldwide Rights to First-in-Class p53 Y220C Cancer Drug FMC-220
10个月前
Delhi High Court Allows Natco Pharma to Continue Cyantraniliprole Insecticide Sales Despite FMC Patent Dispute
去年
NHIA and Roche Expand Partnership to Reduce Cancer Treatment Costs in Nigeria
10个月前
Humacyte's Bioengineered Vessel Shows Superior Performance in High-Risk Dialysis Patients Over Two Years
去年
Navigator Medicines Reports Positive Phase 1a Safety Data for Dual-Target Bispecific Antibody NAV-240
去年
Alembic Pharmaceuticals Receives FDA Approval for Generic Ticagrelor Tablets to Reduce Cardiovascular Risks
5个月前
HMH Holding Completes $210.4 Million IPO Pricing for Drilling Equipment Technology
第 1 页,共 33 页
上一页
下一页